Medline Recalls Angiographic Syringes and Receives FDA Warning Letter

Medline has initiated a recall for certain angiographic syringes due to reports of the devices disconnecting during medical procedures. This issue poses significant health risks, including potential biohazard exposure, blood loss, and life-threatening air embolisms for patients. The recall follows an FDA inspection that resulted in a warning letter citing manufacturing deficiencies, with four serious injuries reported.